{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:02:18Z","timestamp":1776740538901,"version":"3.51.2"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>Secondary leukemia can develop as a recognized side effect of chemotherapy and radiotherapy. In our case, an asymptomatic 61-year-old man was diagnosed with mixed-type Hodgkin lymphoma and underwent treatment with brentixumab-vedotin in 2021. Lately, the <jats:sup>18<\/jats:sup>F-FDG PET\/CT scan we performed due to symptoms, revealed hepatomegaly and a diffusely increased FDG uptake in the liver. Following bone marrow biopsy revealed AML and the scan was consistent with hepatic superscan.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005934","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T01:00:24Z","timestamp":1751590824000},"page":"1035-1036","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Hepatic Superscan on 18F-FDG PET\/CT in a Patient With Secondary Leukemia"],"prefix":"10.1097","volume":"50","author":[{"given":"Ali","family":"G\u00fcm\u00fc\u015f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6126-8384","authenticated-orcid":false,"given":"Merve Nida","family":"Calderon Tobar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonca Kara","family":"Gedik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"R1-20251009","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/MNM.0000000000001601","article-title":"Hepatic superscan on fluorine-18 fluorodeoxyglucose PET\/computed tomography imaging: a specific manifestation for diagnosing lymphoma or leukemia involvement","volume":"43","author":"Wang","year":"2022","journal-title":"Nucl Med Commun"},{"key":"R2-20251009","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/RLU.0b013e3181b53f43","article-title":"FDG hepatic superscan caused by massive breast cancer invasion","volume":"34","author":"Tichelaar","year":"2009","journal-title":"Clin Nucl Med"},{"key":"R3-20251009","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/00003072-200410000-00005","article-title":"Unusually elevated liver radioactivity on F-18 FDG PET in Hodgkin\u2019s disease: hepatic \u201csuperscan","volume":"29","author":"Basu","year":"2004","journal-title":"Clin Nucl Med"},{"key":"R4-20251009","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/RLU.0000000000002134","article-title":"Hepatic Superscan\u201d in a patient with hepatosplenic alphabeta T-cell lymphoma: 18F-FDG PET\/CT findings","volume":"43","author":"Liu","year":"2018","journal-title":"Clin Nucl Med"},{"key":"R5-20251009","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/RLU.0b013e3181e4dcad","article-title":"Hepatic superscan on PET\/CT due to Richter\u2019s transformation of chronic lymphocytic leukemia","volume":"35","author":"Taneja","year":"2010","journal-title":"Clin Nucl Med"},{"key":"R6-20251009","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.11622\/smedj.2013237","article-title":"Hepatic tuberculosis: a rare cause of fluorodeoxyglucose hepatic superscan with background suppression on positron emission tomography","volume":"55","author":"Wong","year":"2014","journal-title":"Singapore Med J"},{"key":"R7-20251009","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/RLU.0000000000004931","article-title":"Hepatic superscan\u201d revealed on 18F-FDG PET due to drug-induced fulminant hepatitis","volume":"49","author":"Qiu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R8-20251009","first-page":"1907","article-title":"Superscan\u201d on 18F-fluorodeoxyglucose positron emission tomography-computed tomography ([18F] FDG PET\/CT)","volume":"71","author":"Muzaffar","year":"2021","journal-title":"J Pak Med Assoc"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:04:33Z","timestamp":1760025873000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005934","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"2024-12-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}